Nick Mordwinkin > Papers
Paper Listing
| Journal: | |
1. N. Mordwinkin, Estimation of glomerular filtration rate by using serum cystatin C and serum creatinine concentrations in patients with human immunodeficiency virus. t 2010; | |
2. N. Mordwinkin, Can therapeutic drug monitoring improve pharmacotherapy of HIV infection in adolescents?. Jun 2010; | |
3. N. Mordwinkin, Aralast: an alpha 1-protease inhibitor for the treatment of alpha-antitrypsin deficiency. t 2007; | |
4. N. Mordwinkin, Discovery and Preclinical Evaluation of a Novel Class of Cytotoxic Propynoic Acid Carbamoyl Methyl-Amides (PACMAs). Oct 2011; | |
5. N. Mordwinkin, Toxicological and toxicokinetic analysis of angiotensin (1-7) in two species. Aug 2011; | |
6. N. Mordwinkin, Interleukin-1 as an Injury Signal Mobilizes Retinyl Esters in Hepatic Stellate Cells through Down Regulation of Lecithin Retinol Acyltransferase. Nov 2011; | |
7. N. Mordwinkin, Angiotensin-(1-7) administration reduces oxidative stress in diabetic bone marrow. Mar 2012; | |
8. N. Mordwinkin, Effects of combined radiation and burn injury on the renin-angiotensin system. Jan 2013; | |
9. N. Mordwinkin, A Review of Human Pluripotent Stem Cell-Derived Cardiomyocytes for High-Throughput Drug Discovery, Cardiotoxicity Screening and Publication Standards. Jan 2013; | |
10. N. Mordwinkin, Alteration of endothelial function in women with gestational diabetes and their fetuses. Feb 2013; | |